Oxford Immunotec welcomes UK NICE guideline on tuberculosis as disease incidence continues to rise

Oxford Immunotec, the producers of an award-winning, revolutionary new immunological blood test for Mycobacterium tuberculosis called T- SPOT.TB, today welcomed the launch of the National Institute for Health and Clinical Excellence (NICE) guideline for managing tuberculosis (TB).

Titled "Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control", the NICE recommendations state that screening for latent TB infection - which has no symptoms and is not infectious but has the potential to develop into TB disease at any time will include administering the unlicensed Mantoux tuberculin skin test in the first instance and, if the results are positive, conducting a further blood test (also known as an interferon-gamma immunological test) to confirm the accuracy of the skin test. More importantly the guidelines confirm the use of blood tests as the first line diagnostic for latent TB in all immunosuppressed individuals, whatever the cause. This includes HIV infection as well as any drug induced immunosuppression, which may occur in groups such as transplant and arthritis patients.

Additionally the guidelines indicate that the blood tests have a role to play in the diagnosis of TB disease especially in non-pulmonary TB and as a rule-out test in TB suspects.

The NICE recommendations for TB come just after The Centers for Disease Control and Prevention (CDC) in the US advised a simple, one-step blood test be used in all circumstances under which the traditional skin test is currently used, as part of its new TB detection guideline.

Oxford Immunotec Chief Executive Officer, Dr. Peter Wrighton-Smith, said: "We welcome NICE's recognition of blood testing and its important role in the diagnosis of latent TB infection. Blood tests for Mycobacterium tuberculosis offer significant advantages over the tuberculin skin test in terms of accuracy, convenience and reliability and this decision represents a

Contact: Natasha Gifford
Virgo Health PR

Page: 1 2 3

Related medicine news :

1. Oxford Open first quarter results show marked differences in uptake across disciplines
2. Epidemic of chronic diseases focus of Oxford Health Alliance Conference
3. Frazer welcomes Federal Government decision on Gardasil
4. Pharmaceutical industry welcomes Labor Partys Innovation Blueprint
5. AAMRI welcomes Canberras fresh commitment to medical research funding
6. Industry welcomes massive Victorian investment in medical research
7. HUP welcomes a Swedish invasion
8. NMDP welcomes IOM recommendation for fully integrated cord blood system
9. ACC/AHA release revised UA/NSTEMI guidelines
10. Quality of treatment guidelines
11. Medical residents unclear about TB guidelines

Post Your Comments:

(Date:9/11/2019)... ... , ... Ahipoki is excited to announce a new vegan and gluten free ... pescatarians and poke bowl fans alike. Ahimi is made of five simple ingredients ... similar to tuna, Ahipoki customers will now have a vegan option when ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... problems facing the ever-changing corporate landscape, Mediaplanet today announces the launch of ... With topics ranging from the importance of candid one-on-one conversations, ideas for ...
(Date:9/9/2019)... ... September 09, 2019 , ... Sharon, ... attended the American Association of Dental Office Management (AADOM) Annual Conference. This year, ... Year (PAOY) award. This is Sharon’s third nomination in a row. The entire ...
(Date:9/8/2019)... DELAND, Fla. (PRWEB) , ... September 09, 2019 , ... ... Best Colleges list of Best Regional Universities – South, released today. In addition, Stetson ... Best Value Schools, No. 11; Most Innovative Universities, No. 14; Campus Ethnic Diversity, No. ...
(Date:9/8/2019)... ... September 06, 2019 , ... ProRehab Louisville has ... injury experts for rehabilitation to young Louisville athletes. , Building off of a ... and fitness programs, the expert physical therapists at ProRehab will be ensuring that ...
Breaking Medicine News(10 mins):
(Date:9/11/2019)... ... September 11, 2019 , ... LifePod® ... innovator HomeThrive has selected LifePod’s voice-first service for rollout to an initial 100 ... over the age of 50, demand has steadily increased for solutions that both ...
(Date:9/11/2019)... ... September 11, 2019 , ... Genedata, the leading ... globally operating Finnish pharmaceutical company, has licensed Genedata Biologics® to support their R&D ... , “As part of our strategy to expand our biopharmaceutical R&D operations, ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... for real time delivery of medical spa treatment approvals, will be speaking on ... at Telehealth Secrets Conference October 2-4, 2019 in Silicon Valley. , Gazaui brings ...
Breaking Medicine Technology:
Cached News: